Beijing Tong Ren Tang Chinese Medicine wins Hong Kong registration certificate for Sanzi Yangqin granules

PUBT · 2d ago
Beijing Tong Ren Tang Chinese Medicine wins Hong Kong registration certificate for Sanzi Yangqin granules
  • Beijing Tong Ren Tang Chinese Medicine won Hong Kong registration for its proprietary Chinese medicine product “Sanzi Yangqin Granules (Tong Ren Tang)”.
  • The certificate allows sales in Hong Kong through Aug. 25, 2031; the product has not yet launched commercially.
  • Cumulative R&D spending on the product totaled about HKD 800,000.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beijing Tong Ren Tang Chinese Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12305557), on August 28, 2026, and is solely responsible for the information contained therein.